British Journal of Haematology: Vol 193, No 3

I consent to Wiley Online Library’s Terms of Use and processing of my personal data as disclosed in Wiley’s Privacy Policy.I consent to my personal information being transferred outside of the People’s Republic of China as laid out in Wiley’s Privacy Policy.*(Optional) I consent to special offers, newsletter & promotions from Wiley. See Privacy Policy for more details.

Tools

Submit an article

Journal Metrics

Subscribe to this journal

Related Title

LATEST ISSUE
Volume 6, Issue 4
August 2025

Posts by @BritSocHaem

British Journal of Haematology

Journal list menu

Tools

Follow journal

British Journal of Haematology: Volume 193, Issue 3

Download PDFs

Issue Information

Issue Information

Images in Haematology

Multiple myeloma with hungry plasma cells

Drop metastases in multiple myeloma

Commentaries

How should we use ibrutinib in patients with mantle cell lymphoma?

Towards ecosystem integration for a better understanding of aggressiveness of B-cell lymphomas

Reviews

CAR-T TREK through the lymphoma universe, to boldly go where no other therapy has gone before

Intravenous iron: do we adequately understand the short- and long-term risks in clinical practice?

COVID-19: Images

COVID-19-associated oxidative damage to red blood cells

Haematological Malignancy – Clinical

Short reports

Temporal changes in survival among adult patients with acute myeloid leukaemia in the period 2000–2016: a Danish population-based study

Expression of the novel tumour suppressor sterile alpha motif and HD domain-containing protein 1 is an independent adverse prognostic factor in classical Hodgkin lymphoma

MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study

Soluble PD-L1 is a promising disease biomarker but does not reflect tissue expression in classic Hodgkin lymphoma

Short reports

Non-Hodgkin lymphoma after treatment for classical Hodgkin lymphoma: a report from the German Hodgkin Study Group

Infiltration of CD163-, PD-L1- and FoxP3-positive cells adversely affects outcome in patients with mantle cell lymphoma independent of established risk factors

Real-world outcomes with bortezomib-containing regimens and lenalidomide plus dexamethasone for the treatment of transplant-ineligible multiple myeloma: a multi-institutional report from the Canadian Myeloma Research Group database

The detection of circulating plasma cells may improve the Revised International Staging System (R-ISS) risk stratification of patients with newly diagnosed multiple myeloma

Short reports

Early relapse after high-dose melphalan autologous stem cell transplant predicts inferior survival and is associated with high disease burden and genetically high-risk disease in multiple myeloma

Insight into del17p low-frequency subclones in chronic lymphocytic leukaemia (CLL): data from the Australasian Leukaemia and Lymphoma Group (ALLG)/CLL Australian Research Consortium (CLLARC) CLL5 trial

Health-related quality of life maintained over time in patients with relapsed or refractory multiple myeloma treated with daratumumab in combination with bortezomib and dexamethasone: results from the phase III CASTOR trial

Haematological malignancy – Biology

Incorporation of somatic panels for the detection of haematopoietic transformation in children and young adults with leukaemia predisposition syndromes and with acquired cytopenias

Molecular dynamics of targeting CD38 in multiple myeloma

Transplantation

Second allogeneic haematopoietic cell transplantation using HLA-matched unrelated versus T-cell replete haploidentical donor and survival in relapsed acute myeloid leukaemia

Paediatrics

Relative expansion of CD19-negative very-early normal B-cell precursors in children with acute lymphoblastic leukaemia after CD19 targeting by blinatumomab and CAR-T cell therapy: implications for flow cytometric detection of minimal residual disease

Short reports

Paediatric chronic myeloid leukaemia presenting in de novo or secondary blast phase - a comparison of clinical and genetic characteristics

Platelets, Thrombosis and Haemostasis

The predictive value of regulatory T cells on glucocorticoid sensitivity in patients with immune thrombocytopenia: a multicentre, prospective clinical study

Haemoglobinopathies

Short reports

Engulfment and cell motility 1 (ELMO1) and apolipoprotein A1 (APOA1) as candidate genes for sickle cell nephropathy

Red Cells and Iron

Short reports

Kidney iron deposition by R2* is associated with haemolysis and urinary iron

Vasculo-toxic and pro-inflammatory action of unbound haemoglobin, haem and iron in transfusion-dependent patients with haemolytic anaemias

Haematopoiesis

Identification of CXCL12-abundant reticular cells in human adult bone marrow

Short reports

Androgen derivatives improve blood counts and elongate telomere length in adult cryptic dyskeratosis congenita

Letters to the Editor

Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis

Immune thrombocytopenia after immune checkpoint inhibitor therapy

Erratum

Erratum

This article corrects the following:

Efficacy and safety of romiplostim in refractory aplastic anaemia: a Phase II/III, multicentre, open-label study

Online only

Using depth of response to stratify patients to front line Autologous Stem Cell Transplant: results of the phase II PADIMAC Myeloma Trial

Outcomes of lenalidomide retreatment with novel triplet regimens in patients with multiple myeloma progressing on lenalidomide-based maintenance therapy

Sign up for email alerts

Tools

More from this journal

NEW: COVID-19 and Haematology

Related Title